This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2026 Jan 13;335(2):124-125.

doi: 10.1001/jama.2025.20965.

Beyond Statins-Expanding the Arsenal of Lipid-Lowering Therapies

Michelle L O'Donoghue¹, Nicholas A Marston¹

Affiliations

PMID: 41206974
DOI: 10.1001/jama.2025.20965

Comment

Beyond Statins-Expanding the Arsenal of Lipid-Lowering Therapies

Michelle L O'Donoghue et al. JAMA. 2026.

. 2026 Jan 13;335(2):124-125.

doi: 10.1001/jama.2025.20965.

Authors

Michelle L O'Donoghue¹, Nicholas A Marston¹

Affiliation

¹ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 41206974
DOI: 10.1001/jama.2025.20965

No abstract available

PubMed Disclaimer

Comment on

Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
Ballantyne CM, Gellis L, Tardif JC, Banka P, Navar AM, Asprusten EA, Scott R, Stroes ESG, Froman S, Mendizabal G, Wang F, Catapano AL. Ballantyne CM, et al. JAMA. 2026 Jan 13;335(2):129-139. doi: 10.1001/jama.2025.20620. JAMA. 2026. PMID: 41206969 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems